Neurodiagnostics Market Size, Scope, Revenue Report 2026 to 2035
Segmentation of Neurodiagnostics Market-
Neurodiagnostics Market By Product-
- Diagnostic and Imaging Systems
- Electroencephalogram (EEG) Systems
- Electromyography (EMG) Products
- Magnetic Resonance Imaging (MRI) Systems
- Ultrasound Imaging Systems
- Computed Tomography (CT) Scanner
- Magnetoencephalogram (MEG) System
- Position emission tomography (PET) System
- Angiography System
- Others
- Clinical Testing Instruments
- PCR
- Next-Generation Sequencing (NGS)
- Sanger Sequencing
- Others
- Reagents & Consumables
- Media and Serra
- Solvents
- Enzymes, Protein & Peptides
- Probes
- Buffers
- Antibodies
- Others
Neurodiagnostics Market By Condition-
- Neuro Degenerative Diseases
- Epilepsy
- Stroke
- Headache Disorders
- Sleep Disorders
- Others
Neurodiagnostics Market By End-Use-
- Hospitals and Surgery Centers
- Neurology Centers
- Ambulatory Care Centers
- Diagnostic Laboratories & Imaging Centers
- Research Laboratories & Academic Institutes
Neurodiagnostics Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Neurodiagnostics Market Snapshot
Chapter 4. Global Neurodiagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter’s Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ Mn), 2026–2035
4.8. Global Neurodiagnostics Market Penetration & Growth Prospect Mapping (US$ Mn), 2025–2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/Impact of AI on Neurodiagnostics Industry Trends
Chapter 5. Neurodiagnostics Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Product:
5.2.1. Diagnostic and Imaging Systems
5.2.1.1. Electroencephalogram (EEG) Systems
5.2.1.2. Electromyography (EMG) Products
5.2.1.3. Magnetic Resonance Imaging (MRI) Systems
5.2.1.4. Ultrasound Imaging Systems
5.2.1.5. Computed Tomography (CT) Scanners
5.2.1.6. Magnetoencephalogram (MEG) Systems
5.2.1.7. Positron Emission Tomography (PET) Systems
5.2.1.8. Angiography Systems
5.2.1.9. Others
5.2.2. Clinical Testing Instruments
5.2.2.1. PCR
5.2.2.2. Next-Generation Sequencing (NGS)
5.2.2.3. Sanger Sequencing
5.2.2.4. Others
5.2.3. Reagents & Consumables
5.2.3.1. Media and Serra
5.2.3.2. Solvents
5.2.3.3. Enzymes, Protein & Peptides
5.2.3.4. Probes
5.2.3.5. Buffers
5.2.3.6. Antibodies
5.2.3.7. Others
Chapter 6. Neurodiagnostics Market Segmentation 2: By Condition, Estimates & Trend Analysis
6.1. Market Share by Condition, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Condition:
6.2.1. Neurodegenerative Diseases
6.2.2. Epilepsy
6.2.3. Stroke
6.2.4. Headache Disorders
6.2.5. Sleep Disorders
6.2.6. Others
Chapter 7. Neurodiagnostics Market Segmentation 3: By End-Use, Estimates & Trend Analysis
7.1. Market Share by End-Use, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following End-Use:
7.2.1. Hospitals and Surgery Centers
7.2.2. Neurology Centers
7.2.3. Ambulatory Care Centers
7.2.4. Diagnostic Laboratories & Imaging Centers
7.2.5. Research Laboratories & Academic Institutes
Chapter 8. Neurodiagnostics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Neurodiagnostics Market Regional Snapshot, 2025 & 2035
8.2. North America
8.2.1. North America Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
8.2.1.1. US
8.2.1.2. Canada
8.2.1.3. Mexico
8.2.2. North America Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022–2035
8.2.3. North America Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2022–2035
8.2.4. North America Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2022–2035
8.3. Europe
8.3.1. Europe Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
8.3.1.1. Germany
8.3.1.2. The UK
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022–2035
8.3.3. Europe Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2022–2035
8.3.4. Europe Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2022–2035
8.4. Asia Pacific
8.4.1. Asia Pacific Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
8.4.1.1. China
8.4.1.2. Japan
8.4.1.3. India
8.4.1.4. South Korea
8.4.1.5. South East Asia
8.4.1.6. Rest of Asia Pacific
8.4.2. Asia Pacific Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022–2035
8.4.3. Asia Pacific Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2022–2035
8.4.4. Asia Pacific Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2022–2035
8.5. Latin America
8.5.1. Latin America Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
8.5.1.1. Brazil
8.5.1.2. Argentina
8.5.1.3. Rest of Latin America
8.5.2. Latin America Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022–2035
8.5.3. Latin America Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2022–2035
8.5.4. Latin America Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2022–2035
8.6. Middle East & Africa
8.6.1. Middle East & Africa Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
8.6.1.1. GCC Countries
8.6.1.2. South Africa
8.6.1.3. Rest of Middle East & Africa
8.6.2. Middle East & Africa Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022–2035
8.6.3. Middle East & Africa Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2022–2035
8.6.4. Middle East & Africa Neurodiagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2022–2035
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Advanced Brain Monitoring
9.2.2. ANT Neuro (Netherlands)
9.2.3. Bio-Rad Laboratories Inc.
9.2.4. Canon, Inc.
9.2.5. DRG Instruments GmbH (Germany)
9.2.6. ELMIKO MEDICAL Sp. Z o.o. (Poland)
9.2.7. Fonar Corporation (US)
9.2.8. FUJIFILM Holdings Corporation
9.2.9. Fujirebio (Japan)
9.2.10. GE Healthcare
9.2.11. Hitachi, Ltd.
9.2.12. Koninklijke Philips N.V.
9.2.13. Lifelines Neuro
9.2.14. Mitsar Co. LTD.
9.2.15. Motion Lab Systems, Inc. (US)
9.2.16. Natus Medical Incorporated
9.2.17. Neusoft Medical Systems Co., Ltd. (US)
9.2.18. Nihon Kohden Corporation
9.2.19. QIAGEN N.V.
9.2.20. Ridge Diagnostics (US)
9.2.21. Rigaku Corporation (Japan)
9.2.22. Siemens Healthcare GmbH
9.2.23. Tecan Trading AG (Switzerland)
9.2.24. Thermo Fisher Scientific, Inc.
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Neurodiagnostic Market Size is valued at USD 8.88 billion in 2025 and is predicted to reach USD 18.09 billion by the year 2035.
Neurodiagnostics Market expected to grow at a 7.5% CAGR during the forecast period for 2026-2035.
GE HealthCare, Koninklijke Philips N.V., Siemens Healthcare GmbH, Hitachi, Ltd., Canon Inc., Lifelines Neuro, Natus Medical Incorporated
Neurodiagnostics Market is segmented based on electroencephalogram systems, electromyography products, magnetic resonance imaging systems.
North American region is leading the Neurodiagnostics Market.